Prescription migraine medication
Pro Research Analysisby 
Searched over 200M research papers
Prescription Migraine Medication: An Overview
Acute Prescription Migraine Medication Usage
Prevalence and Demographics
Acute prescription medications for migraine are used by a significant portion of the population. According to the CaMEO study, 22.9% of respondents reported current use of these medications, while 12.6% had discontinued use, and 64.5% had never used them . Current users of acute prescription medications experienced higher migraine-related disability and symptom severity compared to those who had never used these medications .
Common Medications
The most commonly used acute prescription medications include triptans, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and barbiturates. Triptans were the most frequently reported, used by 47.2% of current users, followed by opioids (37.3%), NSAIDs (31.9%), and barbiturates (12.8%) .
Efficacy of Acute Migraine Medications
Evidence-Based Treatments
The American Headache Society has assessed the efficacy of various pharmacological therapies for acute migraine treatment. Triptans (e.g., sumatriptan, rizatriptan) and dihydroergotamine have strong evidence supporting their effectiveness (Level A) . NSAIDs such as aspirin, diclofenac, ibuprofen, and naproxen, as well as combination therapies like sumatriptan/naproxen, are also effective . However, opioids, while probably effective, are not recommended for regular use due to potential for abuse and adverse effects .
Over-the-Counter vs. Prescription Medications
A study comparing over-the-counter (OTC) medications with prescription drugs found that a combination of acetaminophen, aspirin, and caffeine was more effective than sumatriptan in the early treatment of migraine . This suggests that OTC medications can be a viable first-line treatment for some patients.
Prescription Patterns and Preventive Medications
Prescription Trends
Prescription patterns indicate a higher use of NSAIDs compared to triptans among migraine patients. Anti-inflammatory analgesics were prescribed to 71% of female and 62% of male migraine patients, while triptans were prescribed to 21% of females and 10% of males . This trend suggests a preference for NSAIDs in acute treatment despite the availability of more targeted therapies like triptans.
Preventive Medications
Preventive medications are underutilized, with many patients not receiving appropriate preventive therapy. Beta-blockers, antidepressants, and anticonvulsants are commonly prescribed preventive medications, but their use varies significantly between primary care physicians and specialists . Primary care physicians are less likely to prescribe anticonvulsants and triptans for menstrual migraine compared to specialists .
Conclusion
The management of migraine involves a combination of acute and preventive strategies. While triptans and NSAIDs are commonly used for acute treatment, there is a notable reliance on OTC medications. Preventive treatments are underutilized, particularly in primary care settings. Optimizing migraine management requires a balanced approach that considers the efficacy, side effects, and patient preferences for both acute and preventive therapies.
Sources and full results
Most relevant research papers on this topic